PMID: 9418251Jan 7, 1998Paper

Listeria monocytogenes-infected human umbilical vein endothelial cells: internalin-independent invasion, intracellular growth, movement, and host cell responses

FEMS Microbiology Letters
L GreiffenbergM Kuhn

Abstract

The interaction of Listeria monocytogenes with human umbilical vein endothelial cells was studied. We show that L. monocytogenes invades human umbilical vein endothelial cells independently of internalin A, internalin B, internalin C, and ActA. L. monocytogenes replicates efficiently inside the cells and moves intracellularly by the induction of actin polymerization. We further show that L. monocytogenes-infection of human umbilical vein endothelial cells induces interleukin-6 and interleukin-8 expression during the first 6 h of infection. The expression of MCP-1 and the adhesion molecules VCAM-1 and ICAM-1 was not altered under the experimental conditions used here.

References

Nov 1, 1995·Infection and Immunity·D A DrevetsP A Campbell
Jan 1, 1997·Annual Review of Immunology·M BaggioliniB Moser

❮ Previous
Next ❯

Citations

Nov 19, 2004·Molecular Genetics and Genomics : MGG·J Stritzker, W Goebel
Apr 26, 2000·FEMS Microbiology Letters·J H ParkB S Yoon
Dec 13, 2000·Microbes and Infection·D A Drevets, P J Leenen
May 19, 2000·Infection and Immunity·A Kolb-MäurerW Goebel
Jul 4, 2001·Clinical Microbiology Reviews·J A Vázquez-BolandJ Kreft
Dec 24, 2002·Infection and Immunity·Hélène Réglier-PoupetPatrick Berche
Apr 16, 2004·Clinical Microbiology Reviews·Douglas A DrevetsRonald A Greenfield
Feb 9, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Chen-Chen LeeJaw-Jou Kang
Aug 31, 2018·European Journal of Immunology·Christoph Konradt, Christopher A Hunter
Nov 15, 2002·Journal of Food Protection·Sophia Kathariou
Aug 1, 2018·Infection and Immunity·Christopher C PhelpsStephanie Seveau
Jun 22, 1999·Infection and Immunity·D A Drevets
Aug 1, 2006·Thrombosis Research·Sanjeev K Sahni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.